Maven Securities’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25,000
| Closed | -$272K | – | 624 |
|
|
2023
Q2 | $272K | Sell |
25,000
-10,000
| -29% | -$109K | ﹤0.01% | 216 |
|
|
2023
Q1 | $242K | Hold |
35,000
| – | – | 0.01% | 173 |
|
|
2022
Q4 | $139K | Hold |
35,000
| – | – | ﹤0.01% | 196 |
|
|
2022
Q3 | $233K | Hold |
35,000
| – | – | ﹤0.01% | 366 |
|
|
2022
Q2 | $169K | Hold |
35,000
| – | – | 0.01% | 310 |
|
|
2022
Q1 | $327K | Buy |
35,000
+10,000
| +40% | +$93.4K | 0.01% | 260 |
|
|
2021
Q4 | $297K | Hold |
25,000
| – | – | 0.01% | 274 |
|
|
2021
Q3 | $285K | Hold |
25,000
| – | – | 0.01% | 372 |
|
|
2021
Q2 | $463K | Hold |
25,000
| – | – | 0.02% | 362 |
|
|
2021
Q1 | $379K | Buy |
25,000
+12,500
| +100% | +$190K | 0.02% | 448 |
|
|
2020
Q4 | $154K | Sell |
12,500
-525,800
| -98% | -$6.48M | 0.02% | 482 |
|
|
2020
Q3 | $6.89M | Buy |
538,300
+330,275
| +159% | +$4.23M | 0.57% | 20 |
|
|
2020
Q2 | $2.11M | Buy |
+208,025
| New | +$2.11M | 0.14% | 49 |
|